Smith, M., Naing, A., Bauer, T., Papadopoulos, K. P., Rahma, O., Garralda, E., . . . Kuriakose, E. First-in-human phase 1 study of the arginase inhibitor INCB001158 alone or combined with pembrolizumab in patients with advanced or metastatic solid tumours. BMJ Publishing Group.
Chicago Style (17th ed.) CitationSmith, Michael, et al. First-in-human Phase 1 Study of the Arginase Inhibitor INCB001158 Alone or Combined with Pembrolizumab in Patients with Advanced or Metastatic Solid Tumours. BMJ Publishing Group.
MLA (9th ed.) CitationSmith, Michael, et al. First-in-human Phase 1 Study of the Arginase Inhibitor INCB001158 Alone or Combined with Pembrolizumab in Patients with Advanced or Metastatic Solid Tumours. BMJ Publishing Group.
Warning: These citations may not always be 100% accurate.